Cronos Group Inc. Common Share (CRON) is a publicly traded Healthcare sector company. As of July 26, 2026, CRON trades at $2.81 with a market cap of $1.05B and a P/E ratio of 281.60. CRON moved +2.37% today. Year to date, CRON is +6.84%; over the trailing twelve months it is +35.75%. Its 52-week range spans $1.60 to $3.43. Analyst consensus is buy with an average price target of $3.32. Rallies surfaces CRON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CRON insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.81 |
| Market Cap | $1.05B |
| P/E Ratio | 281.60 |
| EPS | $0.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.43 |
| 52-Week Low | $1.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $159.53M |
| Net Income | $5.06M |
| Gross Margin | 42.73% |
3 analysts cover CRON: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.32.